SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

SCCM Pod-259 NEJM Study Examines if Simvastatin Improves ARDS Outcomes

visual bubble
visual bubble

Todd Fraser, MD, speaks with Daniel F. McAuley, MD, about his article, “Simvastatin in the Acute Respiratory Distress Syndrome,” published in the October 2014 New England Journal of Medicine. McAuley and the Irish Critical Care Trials Group tested the hypothesis that treatment with simvastatin would improve clinical outcomes in patients with acute respiratory distress syndrome (ARDS). Studies in animals and in vitro and phase 2 studies in humans suggest that statins may be beneficial in the treatment of this condition.

*If you are unable to play the podcast please click here to download the file.

Category: Other



Knowledge Area: Pharmacology Pulmonary